About
Small molecule drugs against cancer and autoimmune diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
1
As Collaborator
4
Total Enrollment
143
By Phase
PHASE1: 4EARLY_PHASE1: 1
By Status
NOT_YET_RECRUITING: 3RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07105735Collaborator
RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies
PHASE1Not yet recruiting
18 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2027
NCT07114432Collaborator
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma
PHASE1Not yet recruiting
19 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2028
NCT07072247Collaborator
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
PHASE1Not yet recruiting
9 participants
Started: Jul 10, 2025 · Completed: Jul 30, 2027
NCT06976437Collaborator
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
EARLY_PHASE1Recruiting
21 participants
Started: May 6, 2025 · Completed: Dec 30, 2027
NCT06260527Lead Sponsor
Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers
PHASE1Completed
76 participants
Started: Aug 29, 2023 · Completed: Mar 28, 2024
Locations (1)
Headquarters
Guangzhou, China
Map
Loading map...